...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Endpoints article about Pfizer and M&A

Hi I read the transcript and the only thing to a dumbo like me was the Prostate cancer drug is this the same one we trial.As with. The name is different.Ass regards police I think they watch Rv X,very few post here

Share
New Message
Please login to post a reply